NASDAQ · SHPH
Shuttle Pharmaceuticals Holdings, Inc.
$5.23-$0.01 (-0.19%)
Shuttle Pharmaceuticals Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.22% below the high.
Loading market information…
NASDAQ · AKAN · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Akanda Corp.’s quoted price sits in the lower half of its reported 52-week range, 98.61% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Akanda Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim to provide cannabis-derived items for medical and wellness purposes. Formed in 2021, Akanda Corp. is based out of its main office in New Romney, United Kingdom.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$5.23-$0.01 (-0.19%)
Shuttle Pharmaceuticals Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.22% below the high.
$3.61+$0.24 (+7.12%)
HeartSciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 44.2% below the high.
$2.04-$0.06 (-2.86%)
Jaguar Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.81% below the high.
$0.39-$0.00 (-0.94%)
Bone Biologics Corporation’s quoted price sits in the lower half of its reported 52-week range, 83.75% below the high.
$0.42-$0.01 (-2.66%)
RedHill Biopharma Ltd.’s quoted price sits in the lower half of its reported 52-week range, 73.96% below the high.
$2.04+$0.03 (+1.49%)
Genprex, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.63% below the high.
$1.54-$0.39 (-20.21%)
Universe Pharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.43% below the high.
$1.39-$0.66 (-32.2%)
GlucoTrack, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.33% below the high.
